UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Barriers to Healthy Family Dinners and Preventing Child Obesity: Focus Group Discussions with Parents of 5-to-8-Year-Old Children

Children (Basel), 2023-05, Vol.10 (6), p.952

2023

Volltextzugriff (PDF)

Characterization and modulation of brain lipids content of rainbow trout fed with 100% plant based diet rich in omega-3 long chain polyunsaturated fatty acids DHA and EPA

Biochimie, 2020-11, Vol.178, p.137-147

2020

Volltextzugriff (PDF)

Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus

Clinical infectious diseases, 2020-07, Vol.71 (2), p.363-371

2020

Volltextzugriff (PDF)

Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e702-e709

2023

Volltextzugriff (PDF)

Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)

International journal of epidemiology, 2024-02, Vol.53 (1)

2024

Volltextzugriff (PDF)

Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy

AIDS (London), 2010-07, Vol.24 (12), p.1857-1865

2010

Volltextzugriff (PDF)

Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies

The lancet HIV, 2024-02, Vol.11 (2), p.e106-e116

2024

Volltextzugriff (PDF)

Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV–Hepatitis C Virus Coinfection

The Journal of infectious diseases, 2016-07, Vol.214 (1), p.80-86

2016

Volltextzugriff (PDF)

Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients

AIDS (London), 2012-09, Vol.26 (14), p.1789-1794

2012

Volltextzugriff (PDF)

Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index

PloS one, 2015-06, Vol.10 (6), p.e0129868-e0129868

2015

Volltextzugriff (PDF)

Factors Associated With Discordance Between Absolute CD4 Cell Count and CD4 Cell Percentage in Patients Coinfected With HIV and Hepatitis C Virus

Clinical infectious diseases, 2012-06, Vol.54 (12), p.1798-1805

2012

Volltextzugriff (PDF)

Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV-hepatitis C virus co-infection

AIDS (London), 2011-04, Vol.25 (7), p.967-975

2011

Volltextzugriff (PDF)

Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study

BMC infectious diseases, 2017-01, Vol.17 (1), p.80-80, Article 80

2017

Volltextzugriff (PDF)

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral‐treated HIV/hepatitis C virus‐coinfected patients

HIV medicine, 2015-01, Vol.16 (1), p.24-31

2015

Volltextzugriff (PDF)

Missed Opportunities for Hepatocellular Carcinoma Screening in an HIV/Hepatitis C Virus–Coinfected Cohort

Clinical infectious diseases, 2013-11, Vol.57 (9), p.1339-1342

2013

Volltextzugriff (PDF)

Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV–Coinfected Patients in Clinical Care

Open forum infectious diseases, 2019-03, Vol.6 (3), p.ofz055-ofz055

2019

Volltextzugriff (PDF)

Fibroblast growth factor 23: associations with antiretroviral therapy in patients co‐infected with HIV and hepatitis C

HIV medicine, 2016-05, Vol.17 (5), p.373-379

2016

Volltextzugriff (PDF)

Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals

International journal of molecular sciences, 2015-03, Vol.16 (3), p.6496-6512

2015

Volltextzugriff (PDF)

Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV―HCV-coinfected individuals

Antiviral therapy, 2013-01, Vol.18 (5), p.717-721

2013

Volltextzugriff (PDF)

Reply to Mandorfer et al

Clinical infectious diseases, 2013-03, Vol.56 (6), p.905-906

2013

Volltextzugriff (PDF)

Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries

BMC infectious diseases, 2010-02, Vol.10 (1), p.40-40, Article 40

2010

Volltextzugriff (PDF)

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

The New England journal of medicine, 2014-07, Vol.371 (4), p.326-338

2014

Volltextzugriff (PDF)

Relationship of Chronic Hepatitis C Infection to Rates of AIDS-Defining Illnesses in a Canadian Cohort of HIV Seropositive Individuals Receiving Highly Active Antiretroviral Therapy

HIV clinical trials, 2012-03, Vol.13 (2), p.90-102

2012

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Barriers to Healthy Family Dinners and Preventing Child Obesity: Focus Group Discussions with Parents of 5-to-8-Year-Old Children

Characterization and modulation of brain lipids content of rainbow trout fed with 100% plant based diet rich in omega-3 long chain polyunsaturated fatty acids DHA and EPA

Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus

Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada

Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)

Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy

Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies

Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV–Hepatitis C Virus Coinfection

Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients

Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index

HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality

Factors Associated With Discordance Between Absolute CD4 Cell Count and CD4 Cell Percentage in Patients Coinfected With HIV and Hepatitis C Virus

Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV-hepatitis C virus co-infection

Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral‐treated HIV/hepatitis C virus‐coinfected patients

Missed Opportunities for Hepatocellular Carcinoma Screening in an HIV/Hepatitis C Virus–Coinfected Cohort

Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV–Coinfected Patients in Clinical Care

Fibroblast growth factor 23: associations with antiretroviral therapy in patients co‐infected with HIV and hepatitis C

Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals

Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV―HCV-coinfected individuals

Reply to Mandorfer et al

Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Relationship of Chronic Hepatitis C Infection to Rates of AIDS-Defining Illnesses in a Canadian Cohort of HIV Seropositive Individuals Receiving Highly Active Antiretroviral Therapy

Suchergebnisse filtern